The human telomerase RNA gene (hTERC) is regulated during carcinogenesis but is not dependent on DNA methylation.

Telomerase, the ribonucleoprotein complex involved in telomere maintenance, is composed of two main components: hTERT and hTERC. hTERT seems to be the rate-limiting factor for telomerase activity, although hTERC expression was also shown to correlate to a certain extent with telomerase reactivation. To determine whether the absence of hTERC expression could be the consequence of DNA methylation, we quantified hTERC RNA in 60 human samples (19 telomerase-negative normal tissues, nine telomerase-positive and 22 telomerase-negative tumor tissues, eight telomerase-positive and two telomerase-negative cell lines) using a quantitative dot blot on RT-PCR products. Most of the normal tissues did not express hTERC whereas, in telomerase-positive cell lines and in telomerase-positive tumor tissues, a strong up-regulation was observed, suggesting that hTERC transcription is up-regulated during tumorigenesis. The two telomerase-negative cell lines did not express hTERC. In a series of 22 telomerase-negative soft tissue sarcomas (STS), half did not express hTERC at all, or only weakly, whereas a wide range of expression was observed in the other half. As methylation might be involved in hTERC silencing, we examined the methylation pattern in all samples by direct sequencing and methylation-specific single stand conformation analysis after bisulfite modification. hTERC methylation was never observed, neither in normal nor in tumor tissues. Furthermore, there was no correlation between hTERC expression and proliferation, telomere length or hTERT expression in telomerase-negative STS. In contrast, three of eight telomerase-positive cell lines and the two telomerase negative cell lines were found to be hypermethylated, suggesting that the methylation observed may occur during cell line establishment. In conclusion, this study shows that hTERC expression is indeed regulated during carcinogenesis, but this regulation is unlikely to depend on hTERC methylation, cell proliferation rate, telomere length or hTERT expression.

[1]  L. Guillou,et al.  Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas , 2002, International journal of cancer.

[2]  H. Pickett,et al.  Molecular characterization of inter-telomere and intra-telomere mutations in human ALT cells , 2002, Nature Genetics.

[3]  R. Reddel,et al.  Alternative lengthening of telomeres in mammalian cells , 2002, Oncogene.

[4]  J. Shay,et al.  Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. , 2001, Nucleic acids research.

[5]  J. Campisi,et al.  Cellular senescence, cancer and aging: the telomere connection , 2001, Experimental Gerontology.

[6]  E. Blackburn.  Switching and Signaling at the Telomere , 2001, Cell.

[7]  V. Paradis,et al.  hTERT expression in sporadic renal cell carcinomas , 2001, The Journal of pathology.

[8]  L. Giudice,et al.  Tissue‐specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development , 2001, International journal of cancer.

[9]  F. Bosman,et al.  Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis , 2001, The Journal of pathology.

[10]  M. Osterheld,et al.  Promoter methylation analysis on microdissected paraffin-embedded tissues using bisulfite treatment and PCR-SSCP. , 2001, BioTechniques.

[11]  R. Reddel,et al.  Alternative Lengthening of Telomeres in Human Cells , 2001, Radiation research.

[12]  A. V. D. Van Der Zee,et al.  Lack of telomerase RNA gene hTERC expression in alternative lengthening of telomeres cells is associated with methylation of the hTERC promoter. , 2001, Cancer research.

[13]  S. Goodison,et al.  Telomerase activity in soft-tissue and bone sarcomas. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  R. Reddel,et al.  Telomere maintenance by recombination in human cells , 2000, Nature Genetics.

[15]  M. Hande,et al.  The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo , 2000, Current Biology.

[16]  J. P. Liu,et al.  Telomerase: not just black and white, but shades of gray. , 2000, Molecular cell biology research communications : MCBRC.

[17]  J. Yoo,et al.  Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas. , 2000, Archives of pathology & laboratory medicine.

[18]  R. Glasspool,et al.  Activation of telomerase rna gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. , 2000, Neoplasia.

[19]  S. Bonin,et al.  Catalytic subunit of telomerase expression is related to RNA component expression , 1999, FEBS letters.

[20]  V. Paradis,et al.  Expression of the RNA component of human telomerase (hTR) in prostate cancer, prostatic intraepithelial neoplasia, and normal prostate tissue , 1999, The Journal of pathology.

[21]  C. Fanton,et al.  Confluence-induced alterations in CpG island methylation in cultured normal human fibroblasts. , 1999, Nucleic acids research.

[22]  L. Guillou,et al.  Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. , 1999, Cancer research.

[23]  K. Haruma,et al.  Overexpression of human telomerase RNA is an early event in oesophageal carcinogenesis , 1999, Virchows Archiv.

[24]  H. Stein,et al.  Demonstration of constant upregulation of the telomerase RNA component in human gastric carcinomas using in situ hybridization , 1998, The Journal of pathology.

[25]  E. Parkinson,et al.  Cloning and characterization of human and mouse telomerase RNA gene promoter sequences , 1998, Oncogene.

[26]  S. Kaye,et al.  Tumour specific regulation of telomerase RNA gene expression visualized by in situ hybridization , 1998, Oncogene.

[27]  Y. Shinkai,et al.  Expression profile of the putative catalytic subunit of the telomerase gene. , 1998, Cancer research.

[28]  R. Reddel,et al.  Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines , 1997, Nature Medicine.

[29]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[30]  Gregg B. Morin,et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.

[31]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[32]  J. Jost,et al.  A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. , 1995, Analytical biochemistry.